These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1387313)

  • 21. Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activities.
    Hope WC; Patel BJ; Bolin DR
    Agents Actions; 1991 Sep; 34(1-2):77-80. PubMed ID: 1793057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel anti-inflammatory peptide from human lipocortin 5.
    Perretti M; Becherucci C; Mugridge KG; Solito E; Silvestri S; Parente L
    Br J Pharmacol; 1991 Jun; 103(2):1327-32. PubMed ID: 1832064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid.
    Vishwanath BS; Fawzy AA; Franson RC
    Inflammation; 1988 Dec; 12(6):549-61. PubMed ID: 3220517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity.
    van Binsbergen J; Slotboom AJ; Aarsman AJ; de Haas GH
    FEBS Lett; 1989 Apr; 247(2):293-7. PubMed ID: 2523817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions.
    Camussi G; Tetta C; Bussolino F; Baglioni C
    J Exp Med; 1990 Mar; 171(3):913-27. PubMed ID: 2137857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Group IIA secretory PLA2 inhibition by ursolic acid: a potent anti-inflammatory molecule.
    Nataraju A; Raghavendra Gowda CD; Rajesh R; Vishwanath BS
    Curr Top Med Chem; 2007; 7(8):801-9. PubMed ID: 17456043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limitations of phosphatidylcholine/deoxycholate mixtures for the analysis of phospholipase A2 inhibition and activation: illustration with annexins.
    Davidson FF; Dennis EA
    Biochim Biophys Acta; 1992 Aug; 1127(3):270-6. PubMed ID: 1387325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibition of phospholipase A2 by different lipocortins.
    Weber G; Ferber E
    Biol Chem Hoppe Seyler; 1990 Aug; 371(8):725-31. PubMed ID: 2144971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a series of 1-alkyl ether lipids on inhibition of phospholipase A2 activity and PAF responses.
    Kohler C; Carroll M; Tarrant E; Torley L; Wissner A
    Inflammation; 1993 Jun; 17(3):245-61. PubMed ID: 8330926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.
    Davidson FF; Dennis EA; Powell M; Glenney JR
    J Biol Chem; 1987 Feb; 262(4):1698-705. PubMed ID: 2948959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of normal and psoriatic epidermal phospholipase A2 by picomolar concentrations of recombinant human lipocortin I.
    Cartwright PH; Ilderton E; Sowden JM; Yardley HJ
    Br J Dermatol; 1989 Aug; 121(2):155-60. PubMed ID: 2528367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of copper, iron and zinc on oedema formation induced by phospholipase A2.
    Ferrer X; Moreno JJ
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Jun; 102(2):325-7. PubMed ID: 1358548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.
    Garcia-Pastor P; Randazzo A; Gomez-Paloma L; Alcaraz MJ; Paya M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):166-72. PubMed ID: 10087000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of extracellular phospholipase A2 activity: implications for inflammatory diseases.
    Mukherjee AB; Cordella-Miele E; Miele L
    DNA Cell Biol; 1992 Apr; 11(3):233-43. PubMed ID: 1567556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium-independent phospholipases from guinea pig digestive tract as probes to study the mechanism of lipocortin.
    Gassama-Diagne A; Fauvel J; Chap H
    J Biol Chem; 1990 Mar; 265(8):4309-14. PubMed ID: 2137821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of phospholipase A2 by protein I.
    Khanna NC; Hee-Chong M; Severson DL; Tokuda M; Chong SM; Waisman DM
    Biochem Biophys Res Commun; 1986 Sep; 139(2):455-60. PubMed ID: 2945554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test.
    Cirino G; Peers SH; Flower RJ; Browning JL; Pepinsky RB
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3428-32. PubMed ID: 2470103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variabilin: a dual inhibitor of human secretory and cytosolic phospholipase A2 with anti-inflammatory activity.
    Escrig V; Ubeda A; Ferrandiz ML; Darias J; Sanchez JM; Alcaraz MJ; Paya M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):123-31. PubMed ID: 9223548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteinaceous inhibitors of phospholipase A2 purified from inflammatory sites in rats.
    Suwa Y; Kudo I; Imaizumi A; Okada M; Kamimura T; Suzuki Y; Chang HW; Hara S; Inoue K
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2395-9. PubMed ID: 2320562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Groups I, II and III extracellular phospholipases A2: selective inhibition of group II enzymes by indomethacin but not other NSAIDs.
    Lobo IB; Hoult JR
    Agents Actions; 1994 Mar; 41(1-2):111-3. PubMed ID: 8079814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.